Ashish Shukla
Ashish Shukla, PhD is an independent consultant to the biopharmaceutical industry with over six years of experience in market research and competitive intelligence. His consultancy firm Oncofocus Solutions caters to the primary and secondary research needs of biopharmaceutical companies looking for business solutions in the oncology domain. The firm"s guiding principle is "to become a decision support partner by providing framework driven research support and actionable insights".
Ashish holds a PhD from the German Cancer Research Centre, Heidelberg, Germany and has over seven years of research experience in molecular biology. He has authorship in eight peer-reviewed research papers.
Articles by Ashish Shukla:
Product review of PharmaCircle Business Class Elite (value - help & training; competitors; development; pricing)
Wednesday, 26th September 2018
In the final part of our product review of PharmaCircle Business Class Elite (BCE) we look at the help and training available. The company considers one-to-one customer support its top priority with a team of experts to provide the required support. Its competitors, who include Thomson Reuters' Cortellis, Informa's Pharmaprojects, and Springer Nature's AdisInsight, along with pricing and development plans, including the refinement of its proprietary search technology.
Note: Full review (PDF) at /go/sub/report/3058
Product review of PharmaCircle Business Class Elite (technology - search & user interface; outputs & alerts; administration)
Tuesday, 25th September 2018
The third part of our product review of PharmaCircle Business Class Elite (BCE) for drug, biologics, product development and market landscape. We explore the product's technology, including its proprietary search platform and interface that provides access to apps, outputs and alerts and charting options for areas from patents to labels and development timelines.
Note: Full review (PDF) at /go/sub/report/3058
Product review of PharmaCircle Business Class Elite (sources - content & coverage)
Monday, 24th September 2018
Part two of our product review of PharmaCircle Business Class Elite (BCE) looks at the range of key information sources tracked by the product's analysts and available via its 11 modules and 6 apps, including geographic coverage and languages available.
Note: Full review (PDF) at /go/sub/report/3058
Product review of PharmaCircle Business Class Elite (key advantages; introduction; contact details)
Friday, 21st September 2018
PharmaCircle Business Class Elite (BCE) is an online platform offering continuously updated information on products and pipeline programmes, public and private companies, and global clinical trial records. In this first part of our product review, we take a closer look at the company and product, its users, who include the top 20 pharmaceutical companies, as well as its key features and value.
Note: Full review (PDF) at /go/sub/report/3058
CMOCRO - Supporting the Search for Pharmaceutical Partners
Wednesday, 29th April 2015
The CMOCRO site is a global repository of pharmaceutical suppliers and aims to support its users by providing relevant information regarding the suitability of prospective partners. Reviewer Ashish Shukla highlights a couple of his favourite features of this free-to-use site and what it offers organisations or individuals looking for partnering support.
Reports by Ashish Shukla:
Product review of PharmaCircle Business Class Elite (BCE)
Thursday, 20th September 2018
PharmaCircle Business Class Elite (BCE) is an online resource for professionals in the biopharmaceutical industry. It offers continuously updated and...
Product Review of AdisInsight
Wednesday, 18th March 2015
Product review of the AdisInsight platform. Competitors include Cortellis, Medi-Span, Pharmaprojects and Trialtrove but AdisInsight provides a single...
From information retrieval to integrated intelligence - with Dow Jones
23rd January 2025
AI contracting and licensing; Strategic information managers; End-user training
10th December 2024
- Jinfo Community session (TBC - Mar 2025) (Community) 20th March 2025
- Jinfo Community session (TBC - Feb 2025) (Community) 25th February 2025
- From information retrieval to integrated intelligence - with Dow Jones (Community) 23rd January 2025